Sign in

CIK 0001559053 · Accelerated filer

PROTHENA CORP PUBLIC LTD CO

Sign in to watch
Ticker
PRTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
operating
Phone
011-353-1-236-2500
Business address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
Former names
Prothena Corp plc, Neotope Corp Ltd
  1. 4 Planned sale Chief Scientific Officer sold 4,000 shares at an average $68.16 ($272,648)
  2. 4 Planned sale Director sold 5,000 shares at $67.43 ($337,150)
  3. 4 Planned sale Chief Legal Officer sold 5,000 shares at an average $69.82 ($349,118)
  4. 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $68.90 ($344,494)
  5. 4 Planned sale Chief Medical Officer sold 7,331 shares at $74.00 ($542,494)
  6. 4 Planned sale Chief Operating Officer sold 5,333 shares at an average $73.98 ($394,562)
  7. 4 Planned sale Chief Medical Officer sold 4,669 shares at an average $74.22 ($346,516)
  8. 4 Planned sale Chief Scientific Officer sold 19,000 shares at an average $71.06 ($1,350,224)
  9. 4 Planned sale Chief Regulatory Officer sold 20,000 shares at an average $71.05 ($1,421,009)
  10. 4 Planned sale Chief Legal Officer sold 5,000 shares at an average $64.64 ($323,223)
  11. 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $74.00 ($369,978)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 7 of 25 · 488 filings